ESR1 and breast cancer: Intriguingly, the down-regulation of ERα along with the up-regulation of GPER was discovered in palbociclib-resistant ER+ BC cells, and palbociclib induces pro-inflammatory events via GPER signaling in CAFs, mutually contributing to the decreased sensitivity to CDK4/6 inhibitors.106